Ignite Creation Date:
2024-05-06 @ 2:55 AM
Last Modification Date:
2024-10-26 @ 11:25 AM
Study NCT ID:
NCT02157454
Status:
COMPLETED
Last Update Posted:
2015-11-10
First Post:
2014-05-27
Brief Title:
Effect of a Website Offering Individual Patients Experiences for Cancer Patients
Sponsor:
Berlin School of Public Health
Organization:
Berlin School of Public Health
Study Overview
Official Title:
Randomized Controlled Trial to Evaluate the Effect of a Website Offering Individual Patients Experiences on Patient Competence of Colorectal Cancer Patients
Status:
COMPLETED
Status Verified Date:
2015-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
DIPExRCT
Brief Summary:
Being diagnosed with cancer confronts patients with a severe disease and they need to learn to deal with a range of new challenges In order to support patients in the coping process the website wwwkrankheitserfahrungende provides patients free reliable information about health issues by sharing peoples real-life experiences In our project the investigators developed a new module on the website for patients with colorectal cancer
The objective of our study is to evaluate if access to the new colorectal cancer module on the website wwwkrankheitserfahrungende increases patients competence
The investigators will conduct a two-arm randomized controlled trial Patients affected by colorectal cancer will be randomized into an intervention and a control group the intervention group will have access for two weeks to the website wwwkrankheitserfahrungende colorectal cancer module with cancer patients experiences Patients in the control group will not receive any intervention but will have access to the website for two weeks after completing the study
Patient competence is measured by the self-efficacy component of the German short form of the Cancer Behavior Inventory via an online questionnaire at baseline and after two weeks A second follow-up assessment will be implemented six weeks after baseline
The objective of our study is to evaluate if access to the new colorectal cancer module on the website wwwkrankheitserfahrungende increases patients competence
The investigators will conduct a two-arm randomized controlled trial Patients affected by colorectal cancer will be randomized into an intervention and a control group the intervention group will have access for two weeks to the website wwwkrankheitserfahrungende colorectal cancer module with cancer patients experiences Patients in the control group will not receive any intervention but will have access to the website for two weeks after completing the study
Patient competence is measured by the self-efficacy component of the German short form of the Cancer Behavior Inventory via an online questionnaire at baseline and after two weeks A second follow-up assessment will be implemented six weeks after baseline
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None